Hainan Poly Pharm Co (SZSE:300630) EPS (Basic) : ¥0.85 (TTM As of Sep. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Hainan Poly Pharm Co EPS (Basic)?

Hainan Poly Pharm Co's basic earnings per share (Basic EPS) for the three months ended in Sep. 2023 was ¥0.31. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2023 was ¥0.85.

Hainan Poly Pharm Co's EPS (Diluted) for the three months ended in Sep. 2023 was ¥0.28. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was ¥0.70.

Hainan Poly Pharm Co's EPS without NRI for the three months ended in Sep. 2023 was ¥0.32. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2023 was 0.74.

During the past 12 months, Hainan Poly Pharm Co's average EPS without NRIGrowth Rate was -33.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was 8.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 31.30% per year. During the past 10 years, the average EPS without NRI Growth Rate was 35.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 11 years, Hainan Poly Pharm Co's highest 3-Year average EPS without NRI Growth Rate was 58.70% per year. The lowest was 8.10% per year. And the median was 39.20% per year.

Hainan Poly Pharm Co EPS (Basic) Historical Data

The historical data trend for Hainan Poly Pharm Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Poly Pharm Co EPS (Basic) Chart

Hainan Poly Pharm Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EPS (Basic)

Get a 7-Day Free Trial

0.43

0.71

0.93

0.95

0.96

Hainan Poly Pharm Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
EPS (Basic)	Get a 7-Day Free Trial															0.38	-0.08	0.32	0.30	0.31

Hainan Poly Pharm Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Hainan Poly Pharm Co's Basic EPS for the fiscal year that ended in Dec. 2022 is calculated as

Basic EPS (A: Dec. 2022 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(420.616	-	0)	/	438.141
	=	0.96

Hainan Poly Pharm Co's Basic EPS for the quarter that ended in Sep. 2023 is calculated as

Basic EPS (Q: Sep. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(134.355	-	0)	/	433.402
	=	0.31

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.85

Hainan Poly Pharm Co (SZSE:300630) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Hainan Poly Pharm Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Hainan Poly Pharm Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Hainan Poly Pharm Co (SZSE:300630) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Poly Pharm Co Ltd (SZSE:300630) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

No.1509 Binsheng Road, 10th Floor, Zhejiang Province, Hangzhou, CHN, 310051

Website

http://www.hnpoly.com

Hainan Poly Pharm Co Ltd is a pharmaceutical manufacturer in China. It manufactures injections, oral solid formulations, dry suspension, and other active pharmaceutical ingredients. The products offered by the company include Azithromycin for Injection, Ganciclovir Sodium for Injection. Octreotide Acetate Injection, Trimebutine Maleate tablets, Desloratadine, Trimebutine Maleate, and GANCICLOVIR among others.

Executives

Fan De Zhu	Independent director
Xie Hui Fang	Supervisors
Pu Jian	Executives
Xu Zhao	Securities Affairs Representative
Shen Shi Hua	Executives
Zhou Mao	Directors, Directors, and Executives

Hainan Poly Pharm Co (SZSE:300630) Headlines

No Headlines